25 XP   0   0   10

TrivarX Ltd
Buy, Hold or Sell?

Let's analyse Trivarx together

PenkeI guess you are interested in TrivarX Ltd . Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TrivarX Ltd . At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about TrivarX Ltd

I send you an email if I find something interesting about TrivarX Ltd .

Quick analysis of Trivarx (30 sec.)










What can you expect buying and holding a share of Trivarx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-36.2%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.02 - A$0.03
How sure are you?
50%

1. Valuation of Trivarx (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.07 - A$0.29

Total Value Per Share

A$-0.07 - A$0.29

2. Growth of Trivarx (5 min.)




Is Trivarx growing?

Current yearPrevious yearGrowGrow %
How rich?$4m$4.5m-$523.9k-12.9%

How much money is Trivarx making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$8.2m$6.2m307.9%
Net Profit Margin-14,132.9%-31,781.1%--

How much money comes from the company's main activities?

3. Financial Health of Trivarx (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

What can you expect buying and holding a share of Trivarx? (5 min.)

Welcome investor! Trivarx's management wants to use your money to grow the business. In return you get a share of Trivarx.

What can you expect buying and holding a share of Trivarx?

First you should know what it really means to hold a share of Trivarx. And how you can make/lose money.

Speculation

The Price per Share of Trivarx is A$0.023. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Trivarx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Trivarx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Trivarx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-1.9%0.00-1.9%0.00-17.4%0.00-17.9%-0.01-42.4%
Usd Book Value Change Per Share0.00-5.9%0.00-5.9%0.00-21.6%-0.01-22.5%0.00-1.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-5.9%0.00-5.9%0.00-21.6%-0.01-22.5%0.00-1.7%
Usd Price Per Share0.00-0.00-0.00-0.00-0.07-
Price to Earnings Ratio-1.46--1.46--0.24--2.09--5.98-
Price-to-Total Gains Ratio-0.48--0.48--0.20--0.80--6.73-
Price to Book Ratio0.72-0.72-0.43-0.51-3.94-
Price-to-Total Gains Ratio-0.48--0.48--0.20--0.80--6.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0148856
Number of shares67179
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (67179 shares)-90.45-347.39
Gains per Year (67179 shares)-361.78-1,389.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-362-3720-1390-1400
20-724-7340-2779-2790
30-1085-10960-4169-4180
40-1447-14580-5558-5570
50-1809-18200-6948-6960
60-2171-21820-8337-8350
70-2532-25440-9727-9740
80-2894-29060-11116-11130
90-3256-32680-12506-12520
100-3618-36300-13895-13910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%3.019.01.013.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.013.00.043.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.023.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%10.013.00.043.5%

Fundamentals of Trivarx

About TrivarX Ltd

TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Fundamental data was last updated by Penke on 2024-03-28 01:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of TrivarX Ltd .

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Trivarx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • A Net Profit Margin of -14,132.9% means that $-141.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TrivarX Ltd :

  • The MRQ is -14,132.9%. The company is making a huge loss. -2
  • The TTM is -14,132.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14,132.9%TTM-14,132.9%0.0%
TTM-14,132.9%YOY-31,781.1%+17,648.1%
TTM-14,132.9%5Y-10,770.8%-3,362.1%
5Y-10,770.8%10Y-13,867.7%+3,096.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-14,132.9%-21.2%-14,111.7%
TTM-14,132.9%-20.1%-14,112.8%
YOY-31,781.1%-31.3%-31,749.8%
5Y-10,770.8%-36.1%-10,734.7%
10Y-13,867.7%-45.9%-13,821.8%
1.1.2. Return on Assets

Shows how efficient Trivarx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • -38.7% Return on Assets means that Trivarx generated $-0.39 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TrivarX Ltd :

  • The MRQ is -38.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -38.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.7%TTM-38.7%0.0%
TTM-38.7%YOY-149.9%+111.2%
TTM-38.7%5Y-57.4%+18.7%
5Y-57.4%10Y-51.6%-5.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.7%-6.9%-31.8%
TTM-38.7%-6.8%-31.9%
YOY-149.9%-7.5%-142.4%
5Y-57.4%-6.3%-51.1%
10Y-51.6%-8.6%-43.0%
1.1.3. Return on Equity

Shows how efficient Trivarx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • -49.5% Return on Equity means Trivarx generated $-0.50 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TrivarX Ltd :

  • The MRQ is -49.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -49.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.5%TTM-49.5%0.0%
TTM-49.5%YOY-179.1%+129.5%
TTM-49.5%5Y-71.7%+22.2%
5Y-71.7%10Y-72.0%+0.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.5%-6.8%-42.7%
TTM-49.5%-7.6%-41.9%
YOY-179.1%-7.8%-171.3%
5Y-71.7%-9.6%-62.1%
10Y-72.0%-9.8%-62.2%

1.2. Operating Efficiency of TrivarX Ltd .

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Trivarx is operating .

  • Measures how much profit Trivarx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • An Operating Margin of -8,101.6% means the company generated $-81.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TrivarX Ltd :

  • The MRQ is -8,101.6%. The company is operating very inefficient. -2
  • The TTM is -8,101.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8,101.6%TTM-8,101.6%0.0%
TTM-8,101.6%YOY-6,669.9%-1,431.6%
TTM-8,101.6%5Y-4,180.7%-3,920.8%
5Y-4,180.7%10Y-10,116.9%+5,936.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,101.6%-19.8%-8,081.8%
TTM-8,101.6%-18.2%-8,083.4%
YOY-6,669.9%-24.5%-6,645.4%
5Y-4,180.7%-22.3%-4,158.4%
10Y-10,116.9%-32.1%-10,084.8%
1.2.2. Operating Ratio

Measures how efficient Trivarx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 124.68 means that the operating costs are $124.68 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TrivarX Ltd :

  • The MRQ is 124.676. The company is inefficient in keeping operating costs low. -1
  • The TTM is 124.676. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ124.676TTM124.6760.000
TTM124.676YOY91.868+32.808
TTM124.6765Y61.708+62.968
5Y61.70810Y135.910-74.202
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ124.6761.349+123.327
TTM124.6761.385+123.291
YOY91.8681.389+90.479
5Y61.7081.398+60.310
10Y135.9101.327+134.583

1.3. Liquidity of TrivarX Ltd .

1.3. Liquidity
1.3.1. Current Ratio

Measures if Trivarx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.17 means the company has $0.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TrivarX Ltd :

  • The MRQ is 0.173. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.173. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.1730.000
TTM0.173YOY0.868-0.695
TTM0.1735Y0.949-0.776
5Y0.94910Y0.876+0.073
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1731.744-1.571
TTM0.1731.811-1.638
YOY0.8682.054-1.186
5Y0.9492.588-1.639
10Y0.8762.748-1.872
1.3.2. Quick Ratio

Measures if Trivarx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • A Quick Ratio of 0.12 means the company can pay off $0.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TrivarX Ltd :

  • The MRQ is 0.122. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.122. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.1220.000
TTM0.122YOY0.747-0.626
TTM0.1225Y0.838-0.716
5Y0.83810Y0.739+0.099
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1221.027-0.905
TTM0.1221.188-1.066
YOY0.7471.813-1.066
5Y0.8381.986-1.148
10Y0.7392.012-1.273

1.4. Solvency of TrivarX Ltd .

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Trivarx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Trivarx to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.22 means that Trivarx assets are financed with 21.8% credit (debt) and the remaining percentage (100% - 21.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TrivarX Ltd :

  • The MRQ is 0.218. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.218. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.2180.000
TTM0.218YOY0.163+0.056
TTM0.2185Y0.178+0.040
5Y0.17810Y0.285-0.107
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2180.381-0.163
TTM0.2180.386-0.168
YOY0.1630.414-0.251
5Y0.1780.411-0.233
10Y0.2850.450-0.165
1.4.2. Debt to Equity Ratio

Measures if Trivarx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Trivarx to the Health Information Services industry mean.
  • A Debt to Equity ratio of 27.9% means that company has $0.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TrivarX Ltd :

  • The MRQ is 0.279. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.279. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.279TTM0.2790.000
TTM0.279YOY0.194+0.085
TTM0.2795Y0.238+0.041
5Y0.23810Y0.464-0.226
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2790.602-0.323
TTM0.2790.595-0.316
YOY0.1940.614-0.420
5Y0.2380.719-0.481
10Y0.4640.615-0.151

2. Market Valuation of TrivarX Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Trivarx generates.

  • Above 15 is considered overpriced but always compare Trivarx to the Health Information Services industry mean.
  • A PE ratio of -1.46 means the investor is paying $-1.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TrivarX Ltd :

  • The EOD is -33.530. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.458. Based on the earnings, the company is expensive. -2
  • The TTM is -1.458. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.530MRQ-1.458-32.072
MRQ-1.458TTM-1.4580.000
TTM-1.458YOY-0.242-1.216
TTM-1.4585Y-2.092+0.634
5Y-2.09210Y-5.978+3.886
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-33.530-1.816-31.714
MRQ-1.458-2.188+0.730
TTM-1.458-2.131+0.673
YOY-0.242-3.692+3.450
5Y-2.092-4.987+2.895
10Y-5.978-5.274-0.704
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TrivarX Ltd :

  • The EOD is -32.783. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.425. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.425. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.783MRQ-1.425-31.358
MRQ-1.425TTM-1.4250.000
TTM-1.425YOY-0.200-1.225
TTM-1.4255Y-1.191-0.235
5Y-1.19110Y-11.202+10.011
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-32.783-1.877-30.906
MRQ-1.425-1.927+0.502
TTM-1.425-3.119+1.694
YOY-0.200-5.484+5.284
5Y-1.191-3.847+2.656
10Y-11.202-3.447-7.755
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Trivarx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 0.72 means the investor is paying $0.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TrivarX Ltd :

  • The EOD is 16.613. Based on the equity, the company is expensive. -2
  • The MRQ is 0.722. Based on the equity, the company is cheap. +2
  • The TTM is 0.722. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD16.613MRQ0.722+15.891
MRQ0.722TTM0.7220.000
TTM0.722YOY0.433+0.289
TTM0.7225Y0.511+0.211
5Y0.51110Y3.944-3.432
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD16.6131.894+14.719
MRQ0.7221.837-1.115
TTM0.7221.873-1.151
YOY0.4333.008-2.575
5Y0.5113.981-3.470
10Y3.9444.118-0.174
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TrivarX Ltd .

4. Summary

4.1. Key Performance Indicators

The key performance indicators of TrivarX Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%-0.008+270%-0.008+284%-0.001-71%
Book Value Per Share--0.0010.0010%0.003-60%0.011-88%0.020-93%
Current Ratio--0.1730.1730%0.868-80%0.949-82%0.876-80%
Debt To Asset Ratio--0.2180.2180%0.163+34%0.178+23%0.285-23%
Debt To Equity Ratio--0.2790.2790%0.194+44%0.238+17%0.464-40%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.0010%-0.006+804%-0.006+826%-0.015+2097%
Free Cash Flow Per Share---0.001-0.0010%-0.008+969%-0.008+1041%-0.011+1482%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.006+3594%-0.004+2430%-0.001+312%
Gross Profit Margin--1.0251.0250%1.002+2%1.010+2%1.020+0%
Intrinsic Value_10Y_max--0.289--------
Intrinsic Value_10Y_min---0.071--------
Intrinsic Value_1Y_max--0.003--------
Intrinsic Value_1Y_min---0.010--------
Intrinsic Value_3Y_max--0.030--------
Intrinsic Value_3Y_min---0.028--------
Intrinsic Value_5Y_max--0.080--------
Intrinsic Value_5Y_min---0.043--------
Market Cap7782717.184+42%4547927.1004547927.1000%3076404.920+48%5253266.941-13%40626596.069-89%
Net Profit Margin---141.329-141.3290%-317.811+125%-107.708-24%-138.677-2%
Operating Margin---81.016-81.0160%-66.699-18%-41.807-48%-101.169+25%
Operating Ratio--124.676124.6760%91.868+36%61.708+102%135.910-8%
Pb Ratio16.613+96%0.7220.7220%0.433+67%0.511+41%3.944-82%
Pe Ratio-33.530-2200%-1.458-1.4580%-0.242-83%-2.092+43%-5.978+310%
Price Per Share0.023+96%0.0010.0010%0.002-33%0.005-80%0.115-99%
Price To Free Cash Flow Ratio-32.783-2200%-1.425-1.4250%-0.200-86%-1.191-16%-11.202+686%
Price To Total Gains Ratio-11.056-2200%-0.481-0.4810%-0.195-59%-0.803+67%-6.735+1301%
Quick Ratio--0.1220.1220%0.747-84%0.838-85%0.739-84%
Return On Assets---0.387-0.3870%-1.499+287%-0.574+48%-0.516+33%
Return On Equity---0.495-0.4950%-1.791+261%-0.717+45%-0.720+45%
Total Gains Per Share---0.002-0.0020%-0.008+270%-0.008+284%-0.001-71%
Usd Book Value--4074999.6624074999.6620%4598918.417-11%6605579.103-38%6384511.828-36%
Usd Book Value Change Per Share---0.001-0.0010%-0.005+270%-0.005+284%0.000-71%
Usd Book Value Per Share--0.0010.0010%0.002-60%0.007-88%0.013-93%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%-0.004+804%-0.004+826%-0.010+2097%
Usd Free Cash Flow---2065055.989-2065055.9890%-9957296.910+382%-4559971.215+121%-3834097.001+86%
Usd Free Cash Flow Per Share--0.0000.0000%-0.005+969%-0.005+1041%-0.007+1482%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.004+3594%-0.003+2430%0.000+312%
Usd Market Cap5036974.561+42%2943418.4192943418.4190%1991049.264+48%3399914.364-13%26293532.976-89%
Usd Price Per Share0.015+96%0.0010.0010%0.001-33%0.003-80%0.074-99%
Usd Profit---2019072.429-2019072.4290%-8235295.106+308%-3855736.845+91%-4533486.497+125%
Usd Revenue--14286.29314286.2930%25912.594-45%85675.818-83%75742.075-81%
Usd Total Gains Per Share---0.001-0.0010%-0.005+270%-0.005+284%0.000-71%
 EOD+5 -3MRQTTM+0 -0YOY+21 -135Y+18 -1610Y+18 -16

4.2. Fundamental Score

Let's check the fundamental score of TrivarX Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-33.530
Price to Book Ratio (EOD)Between0-116.613
Net Profit Margin (MRQ)Greater than0-141.329
Operating Margin (MRQ)Greater than0-81.016
Quick Ratio (MRQ)Greater than10.122
Current Ratio (MRQ)Greater than10.173
Debt to Asset Ratio (MRQ)Less than10.218
Debt to Equity Ratio (MRQ)Less than10.279
Return on Equity (MRQ)Greater than0.15-0.495
Return on Assets (MRQ)Greater than0.05-0.387
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of TrivarX Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.903
Ma 20Greater thanMa 500.028
Ma 50Greater thanMa 1000.028
Ma 100Greater thanMa 2000.028
OpenGreater thanClose0.023
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets8,056
Total Liabilities1,760
Total Stockholder Equity6,296
 As reported
Total Liabilities 1,760
Total Stockholder Equity+ 6,296
Total Assets = 8,056

Assets

Total Assets8,056
Total Current Assets304
Long-term Assets7,751
Total Current Assets
Cash And Cash Equivalents 214
Other Current Assets 90
Total Current Assets  (as reported)304
Total Current Assets  (calculated)304
+/-0
Long-term Assets
Property Plant Equipment 107
Intangible Assets 7,629
Long-term Assets Other 15
Long-term Assets  (as reported)7,751
Long-term Assets  (calculated)7,751
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,760
Long-term Liabilities0
Total Stockholder Equity6,296
Total Current Liabilities
Short-term Debt 104
Accounts payable 1,382
Other Current Liabilities 131
Total Current Liabilities  (as reported)1,760
Total Current Liabilities  (calculated)1,616
+/- 143
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock101,801
Retained Earnings -101,705
Accumulated Other Comprehensive Income 6,201
Total Stockholder Equity (as reported)6,296
Total Stockholder Equity (calculated)6,296
+/-0
Other
Capital Stock101,801
Cash and Short Term Investments 214
Common Stock Shares Outstanding 4,547,927
Current Deferred Revenue143
Liabilities and Stockholders Equity 8,056
Net Debt -110
Net Invested Capital 6,296
Net Tangible Assets 1,183
Net Working Capital -1,455
Property Plant and Equipment Gross 107
Short Long Term Debt Total 104



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-30
> Total Assets 
6,999
6,964
5,438
5,135
4,676
2,442
2,062
6,173
2,724
1,409
3,277
5,476
5,419
5,043
15,185
17,921
19,250
19,064
13,303
14,014
17,380
8,488
8,056
8,0568,48817,38014,01413,30319,06419,25017,92115,1855,0435,4195,4763,2771,4092,7246,1732,0622,4424,6765,1355,4386,9646,999
   > Total Current Assets 
1,855
1,779
836
1,143
773
1,835
2,054
4,257
2,175
983
2,500
311
231
238
1,186
3,923
7,365
7,886
1,532
862
2,664
1,200
304
3041,2002,6648621,5327,8867,3653,9231,1862382313112,5009832,1754,2572,0541,8357731,1438361,7791,855
       Cash And Cash Equivalents 
1,645
927
469
1,121
725
1,811
1,955
3,902
2,143
739
1,718
85
181
96
944
1,040
5,010
6,123
1,333
813
2,312
1,033
214
2141,0332,3128131,3336,1235,0101,04094496181851,7187392,1433,9021,9551,8117251,1214699271,645
       Short-term Investments 
0
178
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001780
       Net Receivables 
201
129
360
23
47
23
41
307
25
69
133
48
41
132
233
263
220
1,669
15
33
32
0
0
003233151,6692202632331324148133692530741234723360129201
       Other Current Assets 
9
18
7
0
0
1
58
48
7
14
10
9
9
9
9
2,620
2,135
94
184
17
321
167
90
9016732117184942,1352,62099991014748581007189
   > Long-term Assets 
5,145
5,185
4,602
3,991
3,903
607
8
1,915
549
426
777
5,165
5,188
4,805
13,998
13,998
11,885
11,178
11,771
13,152
14,715
7,288
7,751
7,7517,28814,71513,15211,77111,17811,88513,99813,9984,8055,1885,1657774265491,91586073,9033,9914,6025,1855,145
       Property Plant Equipment 
174
556
316
49
17
10
8
10
12
32
23
4
0
0
0
0
0
0
71
71
23
65
107
107652371710000004233212108101749316556174
       Goodwill 
4,468
4,161
3,853
3,545
3,237
0
0
0
0
50
50
0
0
0
0
0
0
309
0
0
0
0
0
00000309000000505000003,2373,5453,8534,1614,468
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,461
0
0
0
0
0
0
0
0
0
0000000004,4610000000000000
       Intangible Assets 
502
467
432
398
3,237
0
0
780
312
50
250
0
0
944
13,998
13,998
11,885
10,758
11,664
13,002
14,685
7,208
7,629
7,6297,20814,68513,00211,66410,75811,88513,99813,9989440025050312780003,237398432467502
       Other Assets 
0
124
230
0
0
0
0
0
0
0
375
0
0
44
3,122
3,183
2,782
3,074
2,886
3,362
4,388
2,020
15
152,0204,3883,3622,8863,0742,7823,1833,122440037500000002301240
> Total Liabilities 
952
913
288
277
240
184
180
497
262
311
2,099
3,032
2,881
2,332
6,073
9,427
5,936
5,078
4,699
1,404
964
1,382
1,760
1,7601,3829641,4044,6995,0785,9369,4276,0732,3322,8813,0322,099311262497180184240277288913952
   > Total Current Liabilities 
906
879
265
222
165
184
117
413
179
228
2,087
678
2,391
1,931
2,578
6,129
5,936
5,078
4,699
1,404
964
1,382
1,760
1,7601,3829641,4044,6995,0785,9366,1292,5781,9312,3916782,087228179413117184165222265879906
       Short-term Debt 
0
178
11
23
23
0
0
0
0
0
0
0
1,950
1,500
198
395
133
120
2,753
77
25
66
104
1046625772,7531201333951981,5001,95000000002323111780
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,930
198
395
133
120
2,753
0
0
0
0
00002,7531201333951981,9300000000000000
       Accounts payable 
444
222
160
132
110
38
56
271
106
112
389
108
16
141
1,542
517
940
1,235
1,011
1,204
761
1,001
1,382
1,3821,0017611,2041,0111,2359405171,542141161083891121062715638110132160222444
       Other Current Liabilities 
462
479
94
67
32
146
61
143
73
116
1,698
570
425
290
838
5,217
4,864
3,722
934
123
45
314
131
131314451239343,7224,8645,2178382904255701,6981167314361146326794479462
   > Long-term Liabilities 
46
34
23
55
75
0
63
84
83
83
12
2,354
489
401
3,496
3,298
0
0
3,765
1,281
786
1,068
0
01,0687861,2813,765003,2983,4964014892,354128383846307555233446
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,496
3,298
0
0
0
0
0
0
0
00000003,2983,49600000000000000
       Long term Debt 
46
34
23
0
0
0
0
0
0
0
0
2,250
450
395
3,496
3,298
0
0
0
0
0
0
0
00000003,2983,4963954502,25000000000233446
       Other Liabilities 
0
0
0
55
75
0
63
84
83
83
12
104
39
6
0
0
0
0
0
0
0
0
0
000000000639104128383846307555000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
44
3,122
3,183
2,782
2,963
2,779
3,284
4,381
2,005
2,467
2,4672,0054,3813,2842,7792,9632,7823,1833,122440000000000000
> Total Stockholder Equity
6,234
6,012
5,150
4,858
4,436
2,258
1,882
5,676
2,461
1,098
1,178
2,444
2,538
2,710
9,111
8,494
13,314
13,986
8,604
12,609
16,416
7,106
6,296
6,2967,10616,41612,6098,60413,98613,3148,4949,1112,7102,5382,4441,1781,0982,4615,6761,8822,2584,4364,8585,1506,0126,234
   Common Stock
8,038
11,541
13,981
15,971
17,378
19,215
20,268
26,241
26,241
28,085
31,211
35,460
36,651
37,251
51,094
55,756
69,000
83,642
84,425
91,669
96,067
99,446
101,801
101,80199,44696,06791,66984,42583,64269,00055,75651,09437,25136,65135,46031,21128,08526,24126,24120,26819,21517,37815,97113,98111,5418,038
   Retained Earnings -101,705-98,585-85,870-84,383-80,499-73,912-58,072-48,287-42,462-34,541-37,024-35,928-32,601-29,381-26,079-23,044-18,386-16,957-12,942-11,113-8,830-5,529-1,803
   Accumulated Other Comprehensive Income 
-19
-110
-106
-112
-56
-66
-22
2,478
2,299
2,393
2,567
2,912
2,912
2,912
480
1,025
2,386
4,257
4,679
5,323
6,219
6,245
6,201
6,2016,2456,2195,3234,6794,2572,3861,0254802,9122,9122,9122,5672,3932,2992,478-22-66-56-112-106-110-19
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
19
110
0
0
0
0
0
0
0
0
0
0
0
0
480
1,025
2,386
4,257
4,679
5,323
6,219
6,245
6,200
6,2006,2456,2195,3234,6794,2572,3861,02548000000000000011019



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.